Azienda Ulss 3 Serenissima

At Azienda Ulss 3 Serenissima, research in cardiovascular diseases focuses on conditions such as atrial fibrillation, broader cardiovascular disease, and prevention of venous thromboembolism. These studies aim to improve rhythm control, reduce recurrence of blood clots, and evaluate new options for better long-term heart and vessel health.

• atrial fibrillation and rhythm management
• venous thromboembolism recurrence prevention
• new therapies for cardiovascular risk reduction

The site is also involved in studies of metabolic and cardiovascular risk, reflecting a broad effort to test treatments that may improve everyday clinical outcomes.

A major part of the trial portfolio at this Venice hospital site centers on hemic and lymphatic diseases, including acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, non-Hodgkin lymphoma, and Hodgkin lymphoma. The research is designed to test new targeted and combination approaches, while also improving outcomes after transplant and in difficult-to-treat blood cancers.

• targeted treatment for lymphoma subtypes
• new strategies for leukemia and transplant-related care
• improving disease control in relapsed or high-risk blood cancers

This area includes work on multiple myeloma, graft-versus-host disease, and other complex hematologic conditions where better response and durability of treatment are key goals.

Clinical trials in neoplasms at Azienda Ulss 3 Serenissima cover a wide range of cancers, including non-small cell lung cancer, ovarian cancer, endometrial cancer, breast cancer, colorectal cancer, and head and neck cancer. The main purpose is to assess new treatments, compare treatment options, and improve outcomes in both newly diagnosed and recurrent disease.

• testing new therapies for lung cancer and ovarian cancer
• treatment comparisons in breast, endometrial, and colorectal cancer
• studies in head and neck and other solid tumors

The oncology program emphasizes whether newer approaches can extend survival, delay recurrence, or improve disease control for patients with advanced or high-risk cancers.

Research in female urogenital diseases and pregnancy complications and hormonal diseases includes studies in endometrial cancer, ovarian cancer, and treatment-related vasomotor symptoms in women with breast cancer. These trials aim to improve symptom control, support quality of life, and evaluate better treatment approaches for hormone-related conditions.

• symptom relief for vasomotor symptoms
• treatment research in endometrial and ovarian cancer
• improving care for hormone-related health problems

The site’s research in this area links cancer care with broader women’s health needs, especially where hormonal changes affect daily life and treatment choices.

Additional trials at this hospital/clinic explore immune system diseases, nutritional and metabolic diseases, and other pathological conditions. This includes research in chronic graft-versus-host disease, prevention of major cardiovascular events, and supportive approaches that may make cancer treatment easier to tolerate.

• immune-related complications such as graft-versus-host disease
• metabolic and cardiovascular prevention research
• supportive care to improve treatment experience

Overall, the research portfolio combines disease-focused studies with efforts to improve safety, quality of life, and long-term patient outcomes across several specialties.